Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor.
Jiang
J
J
Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Bischof
J
J
D000818:Animals; D003131:Combined Modality Therapy; D003452:Cryosurgery; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems / Q000379:methods; D005260:Female; D007889:Leiomyoma / Q000188:drug therapy* / Q000601:surgery*; D008297:Male; D051379:Mice; D008819:Mice, Nude; D053758:Nanoparticles; D012074:Remission Induction; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology* / Q000633:toxicity; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D014409:Tumor Necrosis Factor-alpha